510(k) Report

510(k) · Cleared

Cleared

Oss Modular Stems, Oss Diaphyseal Segments

K123501510(k) SpecialCleared Feb 27, 2013106-day reviewClass II21 CFR 888.3350

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biomet, Inc. · JDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented

Cleared on Feb 27, 2013 as substantially equivalent to K002757 (Biomet, Inc., 2000) after a 106-day review. Its family tree reaches back 1 generation to 2000. 6 later devices descend from it.

Decided
Feb 27, 2013
Review
106 days
Class
Class II
Product code
JDI
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K002757 (2000). 6 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2015: 2 descendants cleared2014: 1 descendant cleared2013: 1 descendant cleared2026: 2 descendants clearedK002757 · Oncology Salvage System · Biomet, Inc. · 2000 · recalled200020052010201520202025
Descendants, by generation 1 generation forward: 4 descendants2 generations forward: 2 descendants K002757 · Oncology Salvage System · Biomet, Inc. · 2000 · recalled0
  1. Root · 1 generation backK002757 Oncology Salvage SystemBiomet, Inc. · 2000 · Recalled
  2. This deviceK123501 Oss Modular Stems, Oss Diaphyseal SegmentsBiomet, Inc. · 2013
  3. Descendant · cites it directly · 3 of its ownK141331 Biomet Orthopaedic Salvage System (Oss)Biomet, Inc. · 2014
  4. Descendant · 2 generations on · 1 of its ownK142814 Biomet Orthopaedic Salvage System (OSSTM) - Proximal Femoral &…Biomet Manufacturing, LLC · 2015 · Recalled
  5. Descendant · 2 generations on · 0 of its ownK253515 Zimmer Biomet OSS™ Orthopedic Salvage System OsseoTi® Sleeves and…Biomet Orthopedics, Inc. · 2026
  6. Descendant · cites it directly · 0 of its ownK253434 OSSTM Orthopedic Salvage SystemBiomet, Inc. · 2026
  7. Descendant · cites it directly · 0 of its ownK152621 OSS/Arcos IM Total Femur RodBiomet, Inc. · 2015

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2013: 12014: 12015: 22026: 2
2013high 2 (2015) · low 0 (2016)2026

Most influential descendants

Showing 5 of 6 · See all
  • K141331Biomet Orthopaedic Salvage System (Oss)Biomet, Inc. · 2014 · cites it directly3descendants
  • K142814Biomet Orthopaedic Salvage System (OSSTM) - Proximal Femoral & Hybrid TibialBiomet Manufacturing, LLC · 2015 · 2 generations on1descendant
  • K253515Zimmer Biomet OSS™ Orthopedic Salvage System OsseoTi® Sleeves and AugmentsBiomet Orthopedics, Inc. · 2026 · 2 generations on0descendants
  • K253434OSSTM Orthopedic Salvage SystemBiomet, Inc. · 2026 · cites it directly0descendants
  • K152621OSS/Arcos IM Total Femur RodBiomet, Inc. · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K002757Oncology Salvage SystemBiomet, Inc.200014
0 (this device)K123501Oss Modular Stems, Oss Diaphyseal SegmentsBiomet, Inc.2013—
+1K141331Biomet Orthopaedic Salvage System (Oss)Biomet, Inc.2014—
+2K142814Biomet Orthopaedic Salvage System (OSSTM) - Proximal Femoral & Hybrid TibialBiomet Manufacturing, LLC20156
+2K253515Zimmer Biomet OSS™ Orthopedic Salvage System OsseoTi® Sleeves and AugmentsBiomet Orthopedics, Inc.2026—
+1K253434OSSTM Orthopedic Salvage SystemBiomet, Inc.2026—
+1K152621OSS/Arcos IM Total Femur RodBiomet, Inc.2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
201410
201520
202620
FIG. 1 — Lineage of K123501, 2000–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JDI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JDI device

  1. #1 K253515 Zimmer Biomet OSS™ Orthopedic Salvage System…score 15.2 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K002757Oncology Salvage System
Summary page 1
…int femorotibial metal/polymer constrained cemented prosthesis Legally Marketed Devices To Which Substantial Equivalence Is Claimed: K002757 - Oncology Salvage System (Biomet) Device Description: The Orthopedic Salvage System is a system of modular and non-modular comp…
Biomet, Inc.200014

Also cleared against K002757: 20 other devices →

What descends from it? (6)

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K141331Biomet Orthopaedic Salvage System (Oss)Biomet, Inc.20143
K253434OSSTM Orthopedic Salvage SystemBiomet, Inc.20260
K152621OSS/Arcos IM Total Femur RodBiomet, Inc.20150
K131393Mak Oss Femoral Knee ComponentsBiomet Orthopedics Corp.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K141331 (Biomet, Inc., 2014) has gone furthest, with 3 descendants of its own.
  • 20 other devices also cite its predicate K002757.

How does its category compare?

All JDI devices

JDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · JDI

1in 2025

2007: 32008: 52009: 32011: 22012: 42013: 32014: 32015: 32016: 42017: 12018: 12019: 22020: 72021: 32022: 32023: 22024: 32025: 12026 (partial year): 2
2007high 7 (2020) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JDI

59in 2024

2007: 81 days median2008: 96 days median2009: 65 days median2012: 167 days median2013: 176 days median2014: 98 days median2015: 190 days median2016: 166 days median2020: 247 days median2021: 162 days median2022: 69 days median2024: 59 days median
2007high 247 (2020) · low 59 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JDI

1in 2025

2007: 262008: 62009: 32010: 32011: 52012: 42013: 112014: 32015: 12016: 52017: 52018: 12019: 12020: 772025: 1
2007high 77 (2020) · low 0 (2021)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JDI

1,644in 2025

2007: 6962008: 8102009: 9642010: 2,0402011: 3,1602012: 5,1222013: 5,2062014: 4,9682015: 4,9062016: 3,9952017: 6,1352018: 6,7282019: 7,4072020: 4,0152021: 3,1702022: 1,9782023: 1,6352024: 1,8212025: 1,644
2007high 7,407 (2019) · low 696 (2007)2025

MAUDE reports naming product code JDI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200738126696
20085966810
20093653964
20100—32,040
20112—53,160
2012416745,122
20133176115,206
201439834,968
2015319014,906
2016416653,995
20171—56,135
20181—16,728
20192—17,407
20207247774,015
2021316203,170
202236901,978
20232—01,635
202435901,821
20251—11,644
20262—0—

What is it indicated for?

Biomet's Segmental Femoral Replacement components are intended for use in total knee, total hip, or total femoral replacement procedures. Specific indications are: 1. Painful and disabled joint resulting from avascular necrosis, osteoarthritis, rheumatoid arthritis, or traumatic arthritis. 2. Correction of varus, valgus or post-traumatic deformity. 3. Correction or revision of unsuccessful osteotomy, arthrodesis, or previous joint replacement. 4.…

Read the full statement (182 words)

Biomet's Segmental Femoral Replacement components are intended for use in total knee, total hip, or total femoral replacement procedures. Specific indications are:

1. Painful and disabled joint resulting from avascular necrosis, osteoarthritis, rheumatoid arthritis, or traumatic arthritis.

2. Correction of varus, valgus or post-traumatic deformity.

3. Correction or revision of unsuccessful osteotomy, arthrodesis, or previous joint replacement.

4. Ligament deficiencies.

5. Tumor resections.

6. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.*

7. Revision of previously failed total joint arthroplasty.

8. Trauma.

These devices are to be used with bone cement unless a proximal femur is indicated for use (USA).

*Not applicable to Regenerex Ultra Porous Construct titanium knee augment usage (not licensed in Canada), or any other knee component.

When components of the Orthopedic Salvage System are used with Biomet's Compress Segmental Femoral Replacement System, they are intended for uncemented application and indicated for:

1. Correction or revision of unsuccessful osteotomy, arthrodesis, or previous joint replacement.

2. Tumor resections.

3. Revision of previously failed total joint arthroplasty.

4. Trauma.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K123501: Oss Modular Stems, Oss Diaphyseal Segments.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K123501

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026